PharMEDium is recalling 55 lots of various drug products due to a lack of sterility assurance.
Here are four things to know.
1. PharMEDium identified the potentially contaminated drugs after conducting a retrospective review of all medications compounded at the company's Memphis, Tenn. location, per the FDA's request.
2. The recall involves 25,327 units of drug products, which were distributed to hospitals and clinics nationwide.
3. The recalled drugs include various formulations of the pain medications fentanyl citrate and morphine sulfate.
4. PharMEDium has not received any reports of adverse effects related to the recalled products.